Life Sciences Corporate Partnering and Licensing

Why Cooley

40+ professionals across the US, UK and Asia exclusively focused on corporate partnering, licensing and other commercial transactions specific to life sciences companies

Decades of experience across a range of transaction structures, territories, product stages and technologies

Many in the group are backed by a wealth of supporting experience, having been in-house counsel at biotech or major pharmaceutical companies, business consultants and biotech researchers at life sciences companies

42% of the attorneys in our corporate partnering group have earned a bachelor’s degree with a life sciences focus, 30% a Master’s degree and 19% a PhD

Well-versed in the business, regulatory and commercial issues inherent in transactions, with the ability to call on a team of intellectual property, regulatory, reimbursement, tax, antitrust and other specialists as needed

Essentially, we serve as outsourced business advisors for many of our clients

Actively represent 1,900+ public and private life science company clients worldwide

Read more

40+ attorneys around the globe fully dedicated to life sciences corporate partnering & licensing deals


  • LMG Life Sciences: 2022 Licensing & Collaboration Firm of the Year and 2021 Life Sciences Corporate Firm of the Year
  • Chambers USA: Band 1 for Life Sciences
  • Legal 500 US: Tier 1 for Healthcare: Life Sciences in 2021
  • The Deal: 2021 Healthcare, Pharma & Biotech Law Firm & Deal of the Year (Large Cap)
  • The Best Lawyers in America: 2019 Biotechnology Law Firm of the Year